These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 1727896)

  • 1. Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity.
    Oishi K; Koles NL; Guelde G; Pollack M
    J Infect Dis; 1992 Jan; 165(1):34-45. PubMed ID: 1727896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.
    Vreede RW; Leuvenink J; Bouter AS; Brouwer EC; Marcelis JH; Verhoef J
    Eur J Clin Microbiol; 1986 Apr; 5(2):141-7. PubMed ID: 3522225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide.
    Pollack M; Koles NL; Preston MJ; Brown BJ; Pier GB
    Infect Immun; 1995 Nov; 63(11):4481-8. PubMed ID: 7591089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity and function of monoclonal antibodies reactive with discrete structural elements of bacterial lipopolysaccharide.
    Pollack M; Oishi K; Chia J; Evans M; Guelde G; Koles N
    Adv Exp Med Biol; 1990; 256():331-40. PubMed ID: 1691578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.
    Kim KS; Kang JH; Cross AS; Kaufman B; Zollinger W; Sadoff J
    J Infect Dis; 1988 Jan; 157(1):47-53. PubMed ID: 2447199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
    Coughlin RT; Bogard WC
    J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation and protective capacity of monoclonal antibodies elicited in mice against protein epitopes of antibiotic-exposed Escherichia coli.
    Lun MT; Raponi G; Amatucci AM; Natali PG; Fraioli R; Mancini C
    J Med Microbiol; 1997 Feb; 46(2):122-8. PubMed ID: 9060871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1.
    Raff HV; Bradley C; Brady W; Donaldson K; Lipsich L; Maloney G; Shuford W; Walls M; Ward P; Wolff E
    J Infect Dis; 1991 Feb; 163(2):346-54. PubMed ID: 1988519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation.
    Pluschke G; Bordmann G; Daoudaki ME; Lambris JD; Achtman M; Neibert M
    Eur J Immunol; 1989 Jan; 19(1):131-5. PubMed ID: 2646134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial properties of Pseudomonas aeruginosa immunotype 1 lipopolysaccharide-specific monoclonal antibody (MAb) in a murine thigh infection model: combined effects of MAb and ceftazidime.
    Akiyama M; Oishi K; Tao M; Matsumoto K; Pollack M
    Microbiol Immunol; 2000; 44(8):629-35. PubMed ID: 11021392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies reactive with K1-encapsulated Escherichia coli lipopolysaccharide are opsonic and protect mice against lethal challenge.
    Kaufman BM; Cross AS; Futrovsky SL; Sidberry HF; Sadoff JC
    Infect Immun; 1986 May; 52(2):617-9. PubMed ID: 3516883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa.
    Collins MS; Ladehoff DK; Mehton NS; Noonan JS
    FEMS Microbiol Immunol; 1990 Dec; 2(5-6):263-8. PubMed ID: 2127368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
    Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
    Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of hybridoma immunoglobulin switch variants in the analysis of the protective properties of anti-lipopolysaccharide antibodies in Escherichia coli K1 infection.
    Pelkonen S; Pluschke G
    Immunology; 1989 Oct; 68(2):260-4. PubMed ID: 2680911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by two distinct mechanisms.
    Burd RS; Battafarano RJ; Cody CS; Farber MS; Ratz CA; Dunn DL
    Ann Surg; 1993 Sep; 218(3):250-9; discussion 259-61. PubMed ID: 8373268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide.
    Pier GB; Thomas D; Small G; Siadak A; Zweerink H
    Infect Immun; 1989 Jan; 57(1):174-9. PubMed ID: 2491835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides.
    Di Padova FE; Brade H; Barclay GR; Poxton IR; Liehl E; Schuetze E; Kocher HP; Ramsay G; Schreier MH; McClelland DB
    Infect Immun; 1993 Sep; 61(9):3863-72. PubMed ID: 8359907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine monoclonal antibody elicited with antibiotic-exposed Escherichia coli exerts protective capacity in experimental bacterial infections.
    Lun MT; Amatucci AM; Raponi G; Filadoro F; Bartolazzi A; Fraioli R; Natali PG; Mancini C
    J Med Microbiol; 1994 Sep; 41(3):179-83. PubMed ID: 8064837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.